Loring Wolcott & Coolidge Fiduciary Advisors LLP Insulet Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Insulet Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 1,030 shares of PODD stock, worth $236,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,030
Previous 1,030
-0.0%
Holding current value
$236,745
Previous $176,000
17.61%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PODD
# of Institutions
660Shares Held
63.5MCall Options Held
385KPut Options Held
773K-
Vanguard Group Inc Valley Forge, PA8.4MShares$1.93 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.64 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.39 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.86MShares$657 Million0.03% of portfolio
-
Baillie Gifford & CO1.89MShares$434 Million0.3% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $16B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...